Increasing Prevalence of Neurological Disorders and Development of Novel Imaging Software for Neurological Disorders to Augment Growth of Neurovascular Devices Market
Increasing prevalence of neurological disorders is expected to propel growth of the global neurovascular devices market. For instance, according to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Moreover, launch of new products is also expected to aid in growth of the market. For instance, in May 2020, HeadsafeIP Pty Ltd., a privately held brain health technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its NUROCHEK system for brain assessment Development of novel imaging software for neurological disorders is expected to offer lucrative growth opportunities for players in the global neurovascular devices market. For instance, in February 2020, Qynapse, a France-based medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration for its QyScore neurodegenerative disease imaging software. Moreover, increasing geriatri...